FIRE1 implants first patient with vessel sensor in Ireland
FIRE1 aims to enrol a total of 50 patients across European sites in the trial.
FIRE1 aims to enrol a total of 50 patients across European sites in the trial.
The ORFAN study analysed results from 40,000 patients undergoing cardiac computed tomography angiography in the UK.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Vitestro’s robotic blood drawing device meets trial endpoints
Lifespin and Acıbadem University partner for precision medicine platform
FDA’s call for innovation: AI-driven solutions for Parkinson’s freezing of gait detection and prediction
EMVision’s stroke diagnosis AI algorithms show promise in trial